ARA-290

100% delivery

  • Done Satisfaction Guaranteed
  • Done No Hassle Refunds
  • Done Secure Payments
GUARANTEED SAFE CHECKOUT
  • Visa Card
  • MasterCard
SKU: ara-290 Category:

Description

For Research Use Only. Not for Human or Veterinary Use.
Neurological10mg*10vialsHPLC ≥ 99%COA per batch

ARA-290

cibinetide · pHBSP · ARA290 · pyroglutamate helix B surface peptide

Specifications:
Click to preview COA & reports online View all COA
ARA-290
TL;DR

ARA-290 (cibinetide; pHBSP) is a synthetic 11-amino-acid peptide modeled from the aqueous face of erythropoietin helix B. It is supplied for laboratory research as a ligand of the EPOR/CD131 innate repair receptor.(ARA,cibinetide,pHBSP)

Overview

ARA-290 is a linear 11-amino acid peptide of molecular weight 1257 daltons, modeled from the three-dimensional structure of helix B of erythropoietin and used in laboratory studies of the innate repair receptor (EPOR/CD131).

LeadePeptide supplies ARA-290 with full analytical documentation, scalable quantities and dependable worldwide delivery.

What is ARA-290?

ARA-290, also listed as cibinetide and pyroglutamate helix B surface peptide (pHBSP), is an 11-mer assembled to present the aqueous-face residues of erythropoietin helix B (QEQLERALNSS). The N-terminal glutamine undergoes spontaneous, irreversible cyclization to pyroglutamate, so the isolated material is pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser. The peptide is unrelated in primary sequence to erythropoietin; it was made to mimic one feature of EPO’s tertiary structure, not to copy the linear chain.

Receptor context

The innate repair receptor (IRR) is described as a type I cytokine receptor complex of the erythropoietin receptor and the β-common receptor (CD131). ARA-290 is used as a selective ligand of this heteromer. Helix B surface peptide does not contain EPO receptor sites 1 or 2 and, as reported, was not erythropoietic in vitro or in the rat.

Characterization

Each batch is HPLC-purified and mass-confirmed, with identity, purity and net peptide content documented on the COA.

Key Highlights

  • 11-amino-acid helix B surface peptide (pHBSP / cibinetide)
  • Selective IRR ligand (EPOR–CD131); nonerythropoietic in published assays
  • Sequence: pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
  • ≥99% purity verified by HPLC & Mass Spectrometry
  • Lyophilized solid peptide, good stability
  • Full batch-to-batch traceability, COA available for every lot
  • Third-party tested, research-grade raw material

Safety & Side Effects

ARA-290 (cibinetide; pHBSP) is a synthetic 11-amino-acid peptide modeled from the aqueous face of erythropoietin helix B. It is supplied for laboratory research as a ligand of the EPOR/CD131 innate repair receptor.(ARA,cibinetide,pHBSP) When used in research, ARA-290 should be handled in a qualified laboratory setting, and its safety profile should be interpreted strictly within the experimental context in which it was studied.

Published ara-290 side effects data are limited to experimental models and are specific to the dose, route, and study design employed. Investigators should account for neurological and neuroprotective pathways readouts and any off-target effects relevant to the compound’s mechanism when designing a study.

For authoritative safety and toxicology references, consult peer-reviewed databases (PubMed, PubChem) and review the batch Certificate of Analysis before designing your protocol.

Dosage & Protocol

There is no standardized human dosage for ARA-290; it is supplied strictly for laboratory research. Reported ara-290 dosage values in the literature are derived from preclinical studies and are specific to the study model, route, and experimental design.

Research protocols typically document ara-290 dosage together with reconstitution method, storage conditions, and analytical confirmation of identity (CAS 1208243-50-8, molecular formula C51H84N16O21, molecular weight 1257.32 g/mol). Because dose-response relationships may not scale across models, investigators should base their design on peer-reviewed methods rather than informal community reports.

Always confirm the exact strength, purity, and lot-specific data from the batch COA before weighing or reconstituting your sample.

Comparison

PeptideReceptorsCore Characteristic
ARA-290 (pHBSP)EPOR–CD131 (IRR)11-aa pyroglutamate helix B surface peptide
Erythropoietin (EPO)EPOR homodimer and IRREPOR homodimer and IRRFull glycoprotein; erythropoietic
Helix B peptide (HBP)Helix B fragment of EPOLinear helix B sequence (residues 58–82)

How to Order

1

Enquiry

Send strength and quantity for a quote.

2

Quotation

Price, lead time and specification confirmed.

3

QC & COA

HPLC/LC-MS tested; COA issued.

4

Delivery

Tracked worldwide shipping.

Specifications

Product nameARA-290
Product codeRA10
Specification10mg*10vials
CAS number1208243-50-8
Molecular formulaC51H84N16O21
Molecular weight1257.32 g/mol
Purity≥99% (subject to batch COA)
Physical Formlyophilized white solid powder
SolubilitySoluble in bacteriostatic water
Amino Acid Count11 residues

Applications

ResearchLaboratoryAcademicDrug Discovery

Packaging & Shipping

Available pack sizes

10mg*10vials

Shipping

WorldwideCold ChainExpress

Storage & Handling

Store lyophilized at −20 °C, protected from light and moisture. Bring to room temperature before opening. Refrigerate after reconstitution and avoid repeated freeze–thaw cycles.s.

Product Information Q&A

Is ARA-290 third-party tested?

Yes, every batch is third-party tested for purity verification.

Can I view the Certificate of Analysis before purchase?

Corresponding batch COA documents are available upon request.

How should ARA-290 be shipped and stored?

Shipped as lyophilized powder. Store dry powder at −20 °C, away from light and humidity.

What is the amino acid sequence of ARA-290?

The isolated form is pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (pHBSP). The linear precursor is QEQLERALNSS; the N-terminal glutamine cyclizes to pyroglutamate.

How does ARA-290 differ from erythropoietin in research use?

Erythropoietin is a full glycoprotein that binds the EPOR homodimer and the IRR. ARA-290 is an 11-residue helix B surface mimetic used to probe the EPOR/CD131 complex; it lacks EPO sites 1 and 2 and was reported as nonerythropoietic in published assays.